Background: Enterovirus outbreaks caused by Coxsackievirus B4 (CB4) in Taiwan in 2004 and 2008.
Objective: To retrospectively analyze the molecular epidemiology and pathogenicity of CB4 in Taiwan.
Study Design: This study analyzed twenty-three CB4 strains isolated in Taiwan during 1993-2004. Sequence variations data were obtained using 420 bp of VP4/VP2 region and 331 bp of 3' VP1 region. Phylogenetic dendrograms were constructed with other CB4 sequences in Genebank. The clinical manifestations of CB4 infection were examined by retrospectively reviewing medical records of infected patients.
Results: Three CB4 genotypes were identified: genotypes II, IVb and VIII. Genotype VIII, a new and geographically distinct cluster, has been isolated in South Korea, China and Taiwan. This genotype was isolated in twelve of twenty-three CB4 patients treated in Taiwan during 1997-2004. Eight of twenty-three strains belonging to genotype II, now the major genotype worldwide, were first identified in Taiwan in 2000. Three isolates (identified 1993-1994) analyzed in this study belonged to genotype IVb. In this retrospective follow-up study of sixteen patients with CB4 infection, the median patient age at the time of infection diagnosis was 4-year-old (range, 18 days to 10-year-old), and male-female ratio was 1:1. None of the sixteen patients suffered IDDM or myocarditis after their B4 infection episodes; four had Attention Deficit Hyperactivity Disorder (ADHD) and/or tic disorders (TDs) at follow-up.
Conclusions: Genotypes II and VIII of CB4 have co-circulated in Taiwan since 2000. Controlled studies are needed to evaluate a possible association between ADHD and TDs with CB4 infection.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcv.2009.02.012 | DOI Listing |
Microbiology (Reading)
October 2024
School of Infection and Immunology, College of Medical, Veterinary and Life Sciences, Sir Graeme Davies Building, University of Glasgow, Glasgow, G12 8TA, UK.
Front Psychiatry
August 2023
Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Coronavirus disease 2019 dramatically changed people's behavior because of the need to adhere to infection prevention and to overcome general adversity resulting from the implementation of infection prevention measures. However, coping behavior has not been fully distinguished from risk perception, and a comprehensive picture of demographic, risk-perception, and psychobehavioral factors that influence the major coping-behavior factors remain to be elucidated. In this study, we recruited 2,885 Japanese participants.
View Article and Find Full Text PDFHeliyon
June 2023
Biotechnology Advanced Research Centre, Sheda Science and Technology Complex, Abuja, Nigeria.
Essential oils are volatile constituents that give aromatic plants their characteristic odour. The application of these plant actives in food, agriculture, pharmaceutics, and cosmetics has been widely studied. Aromatherapy, a complementary therapy involving the use of essential oils to treat several diseases ranging from microbial infections to metabolic dysfunctions, has been utilised for centuries.
View Article and Find Full Text PDFMetabolites
March 2023
Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
With increased use of mass spectrometry imaging (MSI) in support of pharmaceutical research and development, there are opportunities to develop analytical pipelines that incorporate exploratory high-performance analysis with higher capacity and faster targeted MSI. Therefore, to enable faster MSI data acquisition we present analyte-targeted desorption electrospray ionization-mass spectrometry imaging (DESI-MSI) utilizing a triple-quadrupole (TQ) mass analyzer. The evaluated platform configuration provided superior sensitivity compared to a conventional time-of-flight (TOF) mass analyzer and thus holds the potential to generate data applicable to pharmaceutical research and development.
View Article and Find Full Text PDFJ Med Chem
January 2023
Drugs for Neglected Diseases Initiative, 15 Chemin Camille Vidart, Geneva 1202, Switzerland.
Probing multiple proprietary pharmaceutical libraries in parallel via virtual screening allowed rapid expansion of the structure-activity relationship (SAR) around hit compounds with moderate efficacy against , the causative agent of Chagas Disease. A potency-improving scaffold hop, followed by elaboration of the SAR via design guided by the output of the phenotypic virtual screening efforts, identified two promising hit compounds and , which were profiled further in pharmacokinetic studies and in an model of infection. Compound demonstrated clear reduction of parasitemia in the setting, confirming the interest in this series of 2-(pyridin-2-yl)quinazolines as potential anti-trypanosome treatments.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!